Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Clonal status of actionable driver events and the timing of mutational processes in cancer evolution
Nicholas McGranahan, Francesco Favero, Elza C. de Bruin, et al.
Science Translational Medicine (2015) Vol. 7, Iss. 283
Open Access | Times Cited: 649

Showing 1-25 of 649 citing articles:

Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade
Nicholas McGranahan, Andrew J.S. Furness, Rachel Rosenthal, et al.
Science (2016) Vol. 351, Iss. 6280, pp. 1463-1469
Open Access | Times Cited: 2756
Clonal Heterogeneity and Tumor Evolution: Past, Present, and the Future
Nicholas McGranahan, Charles Swanton
Cell (2017) Vol. 168, Iss. 4, pp. 613-628
Open Access | Times Cited: 2354
Development of tumor mutation burden as an immunotherapy biomarker: utility for the oncology clinic
Timothy A. Chan, Mark Yarchoan, Elizabeth M. Jaffee, et al.
Annals of Oncology (2018) Vol. 30, Iss. 1, pp. 44-56
Open Access | Times Cited: 2264
The PI3K Pathway in Human Disease
David A. Fruman, Honyin Chiu, Benjamin D. Hopkins, et al.
Cell (2017) Vol. 170, Iss. 4, pp. 605-635
Open Access | Times Cited: 2171
A view on drug resistance in cancer
Neil Vasan, José Baselga, David M. Hyman
Nature (2019) Vol. 575, Iss. 7782, pp. 299-309
Open Access | Times Cited: 2065
Comprehensive Characterization of Cancer Driver Genes and Mutations
Matthew H. Bailey, Collin Tokheim, Eduard Porta‐Pardo, et al.
Cell (2018) Vol. 173, Iss. 2, pp. 371-385.e18
Open Access | Times Cited: 2032
Tumor and Microenvironment Evolution during Immunotherapy with Nivolumab
Nadeem Riaz, Jonathan J. Havel, Vladimir Makarov, et al.
Cell (2017) Vol. 171, Iss. 4, pp. 934-949.e16
Open Access | Times Cited: 1893
The somatic mutation profiles of 2,433 breast cancers refine their genomic and transcriptomic landscapes
Bernard Pereira, Suet‐Feung Chin, Oscar M. Rueda, et al.
Nature Communications (2016) Vol. 7, Iss. 1
Open Access | Times Cited: 1459
Tumor aneuploidy correlates with markers of immune evasion and with reduced response to immunotherapy
Teresa Davoli, Hajime Uno, Eric C. Wooten, et al.
Science (2017) Vol. 355, Iss. 6322
Open Access | Times Cited: 1213
T-Cell Transfer Therapy Targeting Mutant KRAS in Cancer
Eric Tran, Paul F. Robbins, Yong‐Chen Lu, et al.
New England Journal of Medicine (2016) Vol. 375, Iss. 23, pp. 2255-2262
Open Access | Times Cited: 1197
deconstructSigs: delineating mutational processes in single tumors distinguishes DNA repair deficiencies and patterns of carcinoma evolution
Rachel Rosenthal, Nicholas McGranahan, Javier Herrero, et al.
Genome biology (2016) Vol. 17, Iss. 1
Open Access | Times Cited: 1087
The evolutionary history of 2,658 cancers
Moritz Gerstung, Clemency Jolly, Ignaty Leshchiner, et al.
Nature (2020) Vol. 578, Iss. 7793, pp. 122-128
Open Access | Times Cited: 909
Targeting the PI3K pathway in cancer: are we making headway?
Filip Janků, Timothy A. Yap, Funda Meric‐Bernstam
Nature Reviews Clinical Oncology (2018) Vol. 15, Iss. 5, pp. 273-291
Closed Access | Times Cited: 903
The Genomic Landscape of Endocrine-Resistant Advanced Breast Cancers
Pedram Razavi, Matthew T. Chang, Guotai Xu, et al.
Cancer Cell (2018) Vol. 34, Iss. 3, pp. 427-438.e6
Open Access | Times Cited: 812
The long tail of oncogenic drivers in prostate cancer
Joshua Armenia, Stephanie A. Wankowicz, David Liu, et al.
Nature Genetics (2018) Vol. 50, Iss. 5, pp. 645-651
Open Access | Times Cited: 758
Pan-cancer analysis of the extent and consequences of intratumor heterogeneity
Noemi Andor, Trevor A. Graham, Marnix Jansen, et al.
Nature Medicine (2015) Vol. 22, Iss. 1, pp. 105-113
Open Access | Times Cited: 723
HER kinase inhibition in patients with HER2- and HER3-mutant cancers
David M. Hyman, Sarina A. Piha‐Paul, Helen Won, et al.
Nature (2018) Vol. 554, Iss. 7691, pp. 189-194
Open Access | Times Cited: 694
Neoantigen vaccine: an emerging tumor immunotherapy
Peng Miao, Yongzhen Mo, Yian Wang, et al.
Molecular Cancer (2019) Vol. 18, Iss. 1
Open Access | Times Cited: 560
From tumour heterogeneity to advances in precision treatment of colorectal cancer
Cornelis J.A. Punt, Miriam Koopman, Louis Vermeulen
Nature Reviews Clinical Oncology (2016) Vol. 14, Iss. 4, pp. 235-246
Closed Access | Times Cited: 556
Genome doubling shapes the evolution and prognosis of advanced cancers
Craig M. Bielski, Ahmet Zehir, Alexander Penson, et al.
Nature Genetics (2018) Vol. 50, Iss. 8, pp. 1189-1195
Open Access | Times Cited: 546
Buparlisib plus fulvestrant versus placebo plus fulvestrant in postmenopausal, hormone receptor-positive, HER2-negative, advanced breast cancer (BELLE-2): a randomised, double-blind, placebo-controlled, phase 3 trial
José Baselga, Seock‐Ah Im, Hiroji Iwata, et al.
The Lancet Oncology (2017) Vol. 18, Iss. 7, pp. 904-916
Open Access | Times Cited: 501
A spatial model predicts that dispersal and cell turnover limit intratumour heterogeneity
Bartłomiej Wacław, Ivana Božić, Meredith E. Pittman, et al.
Nature (2015) Vol. 525, Iss. 7568, pp. 261-264
Open Access | Times Cited: 497
Prospective Genomic Profiling of Prostate Cancer Across Disease States Reveals Germline and Somatic Alterations That May Affect Clinical Decision Making
Wassim Abida, Joshua Armenia, Anuradha Gopalan, et al.
JCO Precision Oncology (2017), Iss. 1, pp. 1-16
Open Access | Times Cited: 472
APOBEC Enzymes: Mutagenic Fuel for Cancer Evolution and Heterogeneity
Charles Swanton, Nicholas McGranahan, Gabriel J. Starrett, et al.
Cancer Discovery (2015) Vol. 5, Iss. 7, pp. 704-712
Open Access | Times Cited: 457
Genomic landscape of lung adenocarcinoma in East Asians
Jianbin Chen, Hechuan Yang, Audrey Su Min Teo, et al.
Nature Genetics (2020) Vol. 52, Iss. 2, pp. 177-186
Open Access | Times Cited: 406
Page 1 - Next Page

Scroll to top